Journal article
Phase I Trial of Inducible Caspase 9 T Cells in Adult Stem Cell Transplant Demonstrates Massive Clonotypic Proliferative Potential and Long-term Persistence of Transgenic T Cells
P Zhang, J Raju, MA Ullah, R Au, A Varelias, KH Gartlan, SD Olver, LD Samson, E Sturgeon, N Zomerdijk, J Avery, T Gargett, MP Brown, LJ Coin, D Ganesamoorthy, C Hutchins, GR Pratt, GA Kennedy, A James Morton, CI Curley Show all
Clinical Cancer Research | AMER ASSOC CANCER RESEARCH | Published : 2019
Abstract
Purpose: Inducible caspase 9 (iCasp9) is a cellular safety switch that can make T-cell therapy safer. The purpose of this phase I trial was to investigate the use of iCasp9-transduced T-cell addback in adult patients undergoing haploidentical stem cell transplantation for high-risk hematologic malignancies. Patients and Methods: Patients undergoing myeloablative, CD34-selected haploidentical stem cell transplantation were treated with 0.51.0 10 6 /kg donor-derived iCasp9-transduced T cells on day þ25 or 26 post-transplant, with additional doses allowed for disease relapse, infection, or mixed chimerism. Results: Three patients were enrolled. iCasp9-transduced T cells were readily detectable ..
View full abstractGrants
Awarded by Spectrum Pharmaceuticals
Funding Acknowledgements
The authors are thankful to the patients and their families for their participation and cooperation. The authors thank Prof. Malcolm K Brenner at the Center for Cell and Gene Therapy (Baylor College of Medicine, Houston, TX) for the manufacture of clinical grade retrovirus vector. The authors thank Bellicum Pharmaceuticals for providing AP1903 (Rimiducid). This study was supported by a Project Grant (APP1053135) from the National Health and Medical Research Council (NH&MRC, Australia), QIMR Berghofer Ride To Conquer Cancer Flagship Award and Royal Brisbane, and Women's Hospital Foundation. S.-K. Tey was supported by an NH&MRC Early Career Fellowship (APP1054786) and G.R. Hill was supported by a Queensland Health Senior Clinical Research Fellowship.